Retinol (vitamin A) and retinoic acid (RA) are essential in the control of epithelial cell growth and cellular differentiation (1, 2) . It has been shown that retinoids prevent cancer in skin and have efficacy as agents in human malignant and premalignant cutaneous disorders (3) . It has also been shown that retinoids cause growth inhibition in many hyperproliferating cell-lines, a feature that makes the compounds of fundamental interest as antitumor and antipsoriatic agents (1, 3) . Retinoids also play fundamental roles both in directing the spatial organization of cells during development and the generation of vertebrate limbs (4) . The elucidation of the function of retinoids in these complex biological processes requires the identification of the specific components of the retinoid signal transduction system as well as the genes directly regulated by this system. Several intracellular retinoic acid binding proteins have been identified, the cellular retinoic acid binding protein (CRABP) and the nuclear retinoic acid receptors (RAR) (1, (5) (6) (7) (8) (9) (10) (11) (12) . The role of the cytoplasmic retinoic acid binding proteins in the transduction of retinoid signal remains undetermined. The direct effect of retinoids may be mediated by the RARs, which act as ligand-inducible transcriptional enhancer factors. These factors belong to the nuclear receptor superfamily of genes, which includes thyroid and steroid hormone receptors (13) . Two different forms of RAR have been characterized in humans (RAR-~ and RAR-/3) (7-10) and a third receptor predominantly expressed in skin (RAR-~,) was recently identified (12) . In a I recent study (14) , it was found that all analogs biologically active in F9 cells bound to RARs, while two of them did not bind to CRABP. These results suggest that retinoids must bind to RARs but not necessarily to CRABP in order to induce cell differentiation. On the other hand, little is known about the affinities of the indMdual RARs for different synthetic retinoic acid analogs. In the present study we have developed an assay where the potency of retinoids on retinoic acid receptor mediated transcriptional regulation can be evaluated.
MATERIALS AND METHODS

Materials
Retinoic acid and 13-cis-retinoic acid were purchased from Sigma Chemical Co. 
Cell transfections and CAT-assays
CV-1 cells were grown in Dulbecco's modified eagles medium (DMEM) containing 10% fetal calf serum. The day before transfection, cells were seeded on 35mm tissue culture dishes in DMEM containing 10% charcoal treated fetal calf serum (ChFCS) at a density of 1.5-2.0 x 105 per dish. Cells were cotransfected using the calcium phosphate co-precipitation technique (15) with 0.6 ~g of hRAR expression vectors (hRARc~0, hRAR/30 or hRAR~t0), 1.2 ~g reporter plasmid and 1.2 /xg of a/3-galactosidase expression vector (pCH110, Pharmacia) used as an internal control to normalize for variations in transfection efficiency. The reporter plasmid (TRE)3-tk-CAT was constructed by ligating synthetic oligonucleotides encoding three palindromic thyroid hormone response elements (TRE; ref. 16) (!TCAGGTCATGACCTGA)3) flanked by HindIII and BamHI sites on the 5'-and 3 ends respectively and cloned into the HindIII -BamHI cloning sites of pBLCAT2 (17) . The construct was confirmed by sequencing. 24 h after transfection, cells were washed once with DMEM, and medium (DMEM, 10%ChFCS) containing different concentrations of retinoids dissolved in DMSO or just DMSO were added to the cells. 24 h later the cells were trypsinized and suspended in medium, pelleted and washed once with 40mM Tris-C1, pH 7.6 containing 150raM NaC1 and lmM EDTA. Cell lysates were prepared by three consecutive freeze-thaw cycles (15) and CATactivity was determined by the xylene extraction method essentially as described (18) . /3-Galactosidase activity was determined in celMysates as described (15) .
RESULTS AND DISCUSSION
Retinoic acid-dependent transcriptional activation of TRE3-CAT by RAR-a, RAR-~ and RAR-~/:
CV-1 cells were transfected with RAR-~, RAR-/3, and RAR--r expression vectors, and the dose response effect of RA on the transcription of the reporter plasmid TRE3-tk-CAT was studied. As can be seen in Figure 1 , there was a dose dependent increase in CAT activity for all three receptors. However, there were differences in the concentration required to give 50% of maximum induction among the three receptors (Table 1) . RAR-oL needed almost 20-fold higher concentrations of RA compared to RAR-~t , and 6-fold higher concentration compared to RAR-/3 to give half maximum induction of CAT activity. The ED50 values for RA obtained in this study ( Figure 1 , table 1) are consistent with a recent report (19) were half maximum induction for the mouse RAR-/3 and RAR-'/ were found to be 2 nM and 0.5 nM respectively. In another recent study (20) an ED50 value of 50 nM was reported for the human RAR-c~ and in another report (9) a 10 fold higher dose was required to activate the reporter gene vit-tk-CAT by the chimeric receptor RAR-o~-ER-CAS compared to RAR-/3-ER-CAS, which also is consistent with what we find in this study. These differences in concentrations required to obtain half maximum induction of CAT activity by the receptors most probably reflect different affinities of each RAR for retinoic acid. This assumption is supported by two recent reports, one where RA was found to have a K d value of 10-15 nM for RAR-o~ (21) and another where a higher affinity of RA to RAR-/~ compared to RAR-~ was observed (22) . These data clearly demonstrate differences in ligand specificity among the RARs.
Differences in retinoid binding between RAR-a, RAR-fl and RAR-~t was also
suggested by the higher evolutionary conservation of the ligand binding domain (E region) for a given RAR subtype (RAR-a, RAR-fl or RAR-"t ) when comparing human and mouse RARs than for all three RARs within a given species (12) .
Potency of RAR-a, RAR-fl and RAR-7 in stimulating transcription by different retinoids:
The ED50 values obtained in the cotransfection assay (see above) most likely reflects the affinity of the receptors to different ligands, while the fold increase of CAT activity probably reflects the interaction of the ligand-receptor complex with the responsive element and its capability to induce transcription. The ED50 values (Table 1) 
Correlation with biological data:
It has been demonstrated that there is a poor correlation between the affinities of some retinoids for RARs and observed biological activities (14) . For example, TTNPB has been found to be 100 -1000 fold more active in vivo, but still has affinities to F9 RARs (14) and HL60 RARs (27) In conclusion our data clearly demonstrate differences in ligand specificity among the RARs, suggesting the possibility of development of new retinoids that selectively activate transcription via one of the receptors. We also find significant differences among the receptors in their potential to activate transcription in this cotransfection system. Whether this reflects intrinsic differences between the three RARs activation functions in their ability to transactivate the TRE3-tk-CAT reporter gene or whether other factors are required to give maximal transcription are presently under investigation.
